Untargeted Metabolomics Screen of Mid‐pregnancy Maternal Serum and Autism in Offspring

Discovering pathophysiologic networks in a blood‐based approach may help to generate valuable tools for early treatment or preventive measures in autism. To date targeted or untargeted metabolomics approaches to identify metabolic features and pathways affecting fetal neurodevelopment have rarely been applied to pregnancy samples, that is, an early period potentially relevant for the development of autism spectrum disorders (ASD). We conducted a...